In vitro activity of moxalactam against anaerobic bacteria.
Moxalactam was tested against 80 isolates of anaerobic bacteria from clinical specimens. The results of this study and a review of other studies, in which comparable susceptibility testing methods were used, demonstrated the susceptibility to moxalactam of members of the Bacteroides fragilis group, Bacteroides melaninogenicus, Fusobacterium species, anaerobic gram-positive cocci, and Clostridium perfringens.
D000693:Anaerobiosis; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D001442:Bacteroides Infections / Q000188:drug therapy; D002511:Cephalosporins / Q000494:pharmacology*; D002513:Cephamycins / Q000494:pharmacology*; D006801:Humans; D009070:Moxalactam
D002511:Cephalosporins; D002513:Cephamycins; D009070:Moxalactam